Searching journal content for articles similar to Rosario et al. 23 (12): 893.

Displaying results 1-10 of 955
For checked items
  1. Research:
    • Pablo Valderrabano,
    • Laila Khazai,
    • Marino E Leon,
    • Zachary J Thompson,
    • Zhenjun Ma,
    • Christine H Chung,
    • Julie E Hallanger-Johnson,
    • Kristen J Otto,
    • Kara D Rogers,
    • Barbara A Centeno,
    • and Bryan McIver
    Evaluation of ThyroSeq v2 performance in thyroid nodules with indeterminate cytology Endocr Relat Cancer 24 (3) 127-136, doi:10.1530/ERC-16-0512 first published on 19 January 2017
    ...to the cytological diagnosis or molecular results, standard World Health Organization criteria were utilized in all cases. We began using the NIFTP designation in 2015 for encapsulated FVPTC after the 2015 United States and Canadian Academy of Pathology annual meeting (March 21–27, Boston, MA, USA), when...
  2. Thematic Review:
    • Hannah Nieto and
    • Kristien Boelaert
    WOMEN IN CANCER THEMATIC REVIEW: Thyroid-stimulating hormone in thyroid cancer: does it matter? Endocr Relat Cancer 23 (11) T109-T121, doi:10.1530/ERC-16-0328 first published on 15 September 2016
    ...of thyroid-stimulating hormone (TSH) to assess functional thyroid status, high resolution ultrasonography (US) scanning to assess the morphological characteristics of the thyroid and nodule(s) and fine needle aspiration for cytological evaluation of the presence of malignancy (Hegedus et al. 2003, Perros et...
  3. Review:
    • Fadi Nabhan and
    • Matthew D Ringel
    Thyroid nodules and cancer management guidelines: comparisons and controversies Endocr Relat Cancer 24 (2) R13-R26, doi:10.1530/ERC-16-0432 first published on 13 December 2016
    ...in the case of medullary thyroid cancer and/or in the case of larger tumors with suspected local invasion or tumors with poor differentiation. Long-term monitoring of patients after hemithyroidectomy requires more studies to determine the appropriate follow-up plan in terms of imaging and appropriate cutoff...
  4. Research:
    • Tae Hyuk Kim,
    • Young-Eun Kim,
    • Soomin Ahn,
    • Ji-Youn Kim,
    • Chang-Seok Ki,
    • Young Lyun Oh,
    • Kyunga Kim,
    • Jae Won Yun,
    • Woong-Yang Park,
    • Jun-Ho Choe,
    • Jung-Han Kim,
    • Jee Soo Kim,
    • Sun Wook Kim,
    • and Jae Hoon Chung
    TERT promoter mutations and long-term survival in patients with thyroid cancer Endocr Relat Cancer 23 (10) 813-823, doi:10.1530/ERC-16-0219 first published on 15 August 2016
    ...overall survival rates for papillary thyroid cancer (PTC), follicular thyroid cancer (FTC) and poorly differentiated/anaplastic thyroid cancer (PDTC/ATC) are approximately 93, 85 and 14%, respectively (Hundahl et  al. 1998). Given the increased likelihood of long-term survival in patients...
  5. Research:
    • Birke Bausch,
    • Ulrich Wellner,
    • Dirk Bausch,
    • Francesca Schiavi,
    • Marta Barontini,
    • Gabriela Sanso,
    • Martin K Walz,
    • Mariola Peczkowska,
    • Georges Weryha,
    • Patrizia Dall'Igna,
    • Giovanni Cecchetto,
    • Gianni Bisogno,
    • Lars C Moeller,
    • Detlef Bockenhauer,
    • Attila Patocs,
    • Karoly Rácz,
    • Dmitry Zabolotnyi,
    • Svetlana Yaremchuk,
    • Iveta Dzivite-Krisane,
    • Frederic Castinetti,
    • David Taieb,
    • Angelica Malinoc,
    • Ernst von Dobschuetz,
    • Jochen Roessler,
    • Kurt W Schmid,
    • Giuseppe Opocher,
    • Charis Eng,
    • and Hartmut P H Neumann
    Long-term prognosis of patients with pediatric pheochromocytoma Endocr Relat Cancer 21 (1) 17-25, doi:10.1530/ERC-13-0415 first published on 29 October 2013
    ...presentations. The European-American-Pheochromocytoma– aganglial tumor developed in Key Words " pheochromocytoma " long-term follow-up " relapse " germline mutations Research B Bausch et al. Patients with pediatric pheochromocytoma 21 :1 17–25eligible registrants, 80% had mutations, 49% VHL, 15% SDHB patient...
  6. Review:
    • V Craig Jordan
    Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer Endocr Relat Cancer 21 (3) R235-R246, doi:10.1530/ERC-14-0092 first published on 21 March 2014
    ...of the Oxford Overview Analysis. Each of these factors was essential to propel the progress of tamoxifen to evolve as an essential part of the fabric of society. Endocrine-Related Cancer (2014) 21, R235–R246"lsbreast endocrine therapyAbstractTamoxifen as the first ta long-term adjuvant thera breast cancer V...
  7. Research:
    • Gabriela Franco Mourão,
    • Pedro Weslley Rosario,
    • and Maria Regina Calsolari
    Low postoperative nonstimulated thyroglobulin as a criterion to spare radioiodine ablation Endocr Relat Cancer 23 (1) 47-52, doi:10.1530/ERC-15-0458 first published on 26 October 2015
    ...) and nonaggressive histology (Rosario et al. 2004a, 2007) and patients with the noninvasive encapsulated follicular variant of papillary carcinoma (E-FVPTC; Rosario et al. 2014a), who clearly would not benefit from ablation with 131I, were excluded. Patients with one of the following characteristics were also...
  8. Review:
    • Louis de Mestier,
    • Clarisse Dromain,
    • Gaspard d'Assignies,
    • Jean-Yves Scoazec,
    • Nathalie Lassau,
    • Rachida Lebtahi,
    • Hedia Brixi,
    • Emmanuel Mitry,
    • Rosine Guimbaud,
    • Frédéric Courbon,
    • Michèle d'Herbomez,
    • and Guillaume Cadiot
    Evaluating digestive neuroendocrine tumor progression and therapeutic responses in the era of targeted therapies: state of the art Endocr Relat Cancer 21 (3) R105-R120, doi:10.1530/ERC-13-0365 first published on 18 December 2013
    ..." targeted therapies " biomarker " CT scan " contrast-enhanced imaging " ultrasonography " MRI " isotopic imaging Endocrine-Related Cancer (2014) 21, R105–R120 Review L de Mestier et al. Neuroendocrine tumor evaluation 21 :3 R105–R120Well-differentiated neuroendocrine tumors (NETs) are rare comparison...
  9. Research:
    • Maria Denaro,
    • Clara Ugolini,
    • Anello Marcello Poma,
    • Nicla Borrelli,
    • Gabriele Materazzi,
    • Paolo Piaggi,
    • Massimo Chiarugi,
    • Paolo Miccoli,
    • Paolo Vitti,
    • and Fulvio Basolo
    Differences in miRNA expression profiles between wild-type and mutated NIFTPs Endocr Relat Cancer 24 (10) 543-553, doi:10.1530/ERC-17-0167
    ..., Pisa, Italy 3National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, Arizona, USA 4Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy Abstract Noninvasive encapsulated follicular variants of papillary thyroid carcinomas have been recently reclassified...
  10. Review:
    • Wassim Chemaitilly and
    • Charles A Sklar
    Endocrine complications in long-term survivors of childhood cancers Endocr Relat Cancer 17 (3) R141-R159, doi:10.1677/ERC-10-0002 first published on 7 May 2010
    ...system ma) are at rine compli2006). Such thyroid gland, and the gonads; they can also affect bone nd glucose iew aims at e problems observed in childhood cancer survivors. Disorders of the hypothalamic– Endocrine-Related Cancer (2010) 17 R141–R1592009). The CCSS continues to generate data on long-term...
For checked items

Search Results

Next 10 » New Search

Modify Results

Citation format:
Results / page:
Results order:

This search

  • Alert me when new articles matching this search are published
  • Download all citations on this page to my citation manager

New Articles: issue in progress

  1. December 2017, 24 (12)
  1. Current Issue
  1. Alert me to new issues of Endocrine-Related Cancer

Most